Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Curtit

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 15, 2017
Prognostic and predictive indicators in early-stage breast cancer and the role of genomic profiling: Focus on the Oncotype DX<sup>®</sup> Breast Recurrence Score AssayE Curtit, L Mansi, Y Maisonnette-Escot, et al.
Revue Neurologique|April 8, 2015
[Mnesic disorders caused by left temporal gliomas]C Verlut, G Sylvestre, E Curtit, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 2011
Impact of sunitinib pharmacokinetic monitoring in a patient with metastatic renal cell carcinoma undergoing hemodialysisA Thiery-Vuillemin, D Montange, E Kalbacher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 17, 2012
Hemodialysis does not affect everolimus pharmacokinetics: two cases of patients with metastatic renal cell cancerA Thiery-Vuillemin, E Curtit, T Maurina, et al.
European Journal of Cancer (Oxford, England : 1990)|September 17, 2011
Myotax: a phase II trial of docetaxel plus non-pegylated liposomal doxorubicin as first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclinesE Curtit, P Nouyrigat, N Dohollou, et al.
Medical Oncology (Northwood, London, England)|July 13, 2016
Metronomic cyclophosphamide therapy in hormone-naive patients with non-metastatic biochemical recurrent prostate cancer: a phase II trialFabien Calcagno, Guillaume Mouillet, Olivier Adotevi, et al.
BMC Cancer|November 3, 2019
Systemic high-dose intravenous methotrexate in patients with central nervous system metastatic breast cancerF Bazan, E Dobi, B Royer, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 15, 2017
Prognostic and predictive indicators in early-stage breast cancer and the role of genomic profiling: Focus on the Oncotype DX<sup>®</sup> Breast Recurrence Score AssayE Curtit, L Mansi, Y Maisonnette-Escot, et al.
Revue Neurologique|April 8, 2015
[Mnesic disorders caused by left temporal gliomas]C Verlut, G Sylvestre, E Curtit, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 2011
Impact of sunitinib pharmacokinetic monitoring in a patient with metastatic renal cell carcinoma undergoing hemodialysisA Thiery-Vuillemin, D Montange, E Kalbacher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 17, 2012
Hemodialysis does not affect everolimus pharmacokinetics: two cases of patients with metastatic renal cell cancerA Thiery-Vuillemin, E Curtit, T Maurina, et al.
European Journal of Cancer (Oxford, England : 1990)|September 17, 2011
Myotax: a phase II trial of docetaxel plus non-pegylated liposomal doxorubicin as first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclinesE Curtit, P Nouyrigat, N Dohollou, et al.
Medical Oncology (Northwood, London, England)|July 13, 2016
Metronomic cyclophosphamide therapy in hormone-naive patients with non-metastatic biochemical recurrent prostate cancer: a phase II trialFabien Calcagno, Guillaume Mouillet, Olivier Adotevi, et al.
BMC Cancer|November 3, 2019
Systemic high-dose intravenous methotrexate in patients with central nervous system metastatic breast cancerF Bazan, E Dobi, B Royer, et al.
Pageof 1